Caidya®

CMC Considerations in Development of Cell Therapies

CMC Considerations for Cell Therapies

Learn the essential CMC considerations for cell therapies, from sourcing and manufacturing controls to regulatory strategies and release testing best practices.

Download the White Paper

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

News

09/19/2025

Caidya Appoints Dr. Bin Peng as Chair of its China Scientific Advisory Board

RALEIGH, N.C.; September 19, 2025 – Caidya, a leading global...
Read more

News

07/21/2025

Caidya’s John Wang Named Chair of China CDISC Coordinating Committee; Medidata Accreditation Underscores Data Management Excellence

RALEIGH, N.C.; July 22, 2025 – Caidya a global, technology-enabled clinical...
Read more

News

03/13/2025

Caidya Strengthens Therapeutic Leadership: Names Adam Callahan Head of Oncology and Hematology

RALEIGH, N.C.; Mar. 13, 2025 – Caidya, a leading global,...
Read more
Skip to toolbar